CHTP: Summary for Chelsea Therapeutics Internatio - Yahoo! Canada Finance

	Sign In [New User? Sign Up]	Finance Home \|Help

Wednesday, February 10, 2010, 2:04am EST - Canadian Markets open in 7 hours and 26 minutes.

To create a watchlist or portfolio of shares, Sign-in or Register

Chelsea Therapeutics International Ltd. (CHTP)

On Feb 9: 2.53 USD

0.19 (6.99%)

MORE ON CHTP

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Chelsea Therapeutics Internatio (NCM:CHTP) Delayed quote data

After Hours: 2.53 0.00 (0.00%) as of 4:34pm EST on 02/09/10

Last Trade:	2.53 USD
Trade Time:	Feb 9
Change:	0.19 (6.99%)
Prev Close:	2.72
Open:	2.76
Bid:	2.21 x 100
Ask:	2.85 x 200
1y Target Est:	6.67

Day's Range:	2.47 - 2.79
52wk Range:	1.27 - 7.51
Volume:	690,563
Avg Vol (3m):	394,181
Market Cap:	84.76M
P/E (ttm):	N/A
EPS (ttm):	-0.94
Div & Yield:	N/A (N/A%)

Chelsea Therapeutics International Ltd. (CHTP)

1d 5d 3m 6m 1y 2y 5y

Add CHTP to Portfolio

Download Data

HEADLINES

•	CHELSEA THERAPEUTICS INTERNATIONAL, LTD. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhib
	EDGAR Online (Tue 1:29pm)

•	InPlay: Chelsea Therapeutics announces several updates related to its Phase III registration program in neurogenic orthostatic hypotension
	Briefing.com (Tue 7:33am)

•	How the Brokers Stack Up
	at Barrons.com (Fri, Feb 5)

•	[video] Trading Smallcap Biotech
	at TheStreet.com (Mon, Feb 1)

•	Insider Sells $8.3M Worth of Complete Production Svs
	TheStreet.com (Thu, Jan 21)

•	GenVec, Allied Defense: Early Volume Plays
	at TheStreet.com (Tue, Jan 19)

•	CHELSEA THERAPEUTICS INTERNATIONAL, LTD. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhib
	EDGAR Online (Wed, Dec 16)

•	CHELSEA THERAPEUTICS INTERNATIONAL, LTD. Financials
	EDGAR Online Financials (Fri, Nov 6)

•	Biotech Stock Mailbag: Poniard Predictions
	at TheStreet.com (Fri, Nov 6)

•	YRC Worldwide: Midday Volume Movers
	at TheStreet.com (Tue, Nov 3)

More Headlines for CHTP...

ANALYST

EPS Est (next year) (Dec-09) :	-0.90
EPS Est (in 2 years) (Dec-10) :	-1.04
Avg Rec (current)*:	1.6
PEG Ratio:	N/A

* (Strong Buy) 1.0 - 5.0 (Strong Sell)

Analyst Opinion - Estimates

BUSINESS SUMMARY

Chelsea Therapeutics International, Ltd., a development stage pharmaceutical company, focuses on the acquisition, development, and commercialization of pharmaceutical products for the treatment of various human diseases.

Full Company Profile

Add to Portfolio

Email to a Friend

•